Abstract
Cannabicitran is a cannabinoid found in levels up to ~10% in commercial “purified” cannabidiol (CBD) extracts. The structure of this natural product was first reported more than 50 years ago. However, few studies have investigated cannabicitran or its origin despite the rapidly increasing interest in the use of cannabinoids for the treatment of a wide range of physiological conditions. Following on a recent detailed NMR and computational characterization of cannabicitran, our group initiated ECD and TDDFT studies aimed at unequivocally determining the absolute configuration of cannabicitran present in Cannabis sativa extracts. To our surprise, we discovered the natural product was racemic, raising questions around its presumed enzymatic origin. Herein, we report the isolation and absolute configuration of (-)-cannabicitran and (+)-cannabicitran. Several possible scenarios for production of the racemate in the plant and/or during extract processing are discussed.
Keywords: CBT-C, DFT calculations, ECD, NMR, OR, TDDFT, VCD, cannabicitran, cannabinoids
© 2023 The Authors. Chirality published by Wiley Periodicals LLC.
Similar articles
-
Calculated and experimental 1 H and 13 C NMR assignments for cannabicitran.Magn Reson Chem. 2022 Feb;60(2):196-202. doi: 10.1002/mrc.5224. Epub 2021 Oct 27.PMID: 34617621
-
Synthetic Strategies for Rare Cannabinoids Derived from Cannabis sativa.J Nat Prod. 2022 Jun 24;85(6):1555-1568. doi: 10.1021/acs.jnatprod.2c00155. Epub 2022 Jun 1.PMID: 35648593 Review.
-
Selective Preparation and High Dynamic-Range Analysis of Cannabinoids in “CBD Oil” and Other Cannabis sativa Preparations.J Nat Prod. 2022 Mar 25;85(3):634-646. doi: 10.1021/acs.jnatprod.1c00976. Epub 2022 Jan 6.PMID: 34990123 Free PMC article.
-
Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L.Phytochem Anal. 2005 Jan-Feb;16(1):45-8. doi: 10.1002/pca.809.PMID: 15688956
-
The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.Inflamm Res. 2020 Jun;69(6):549-558. doi: 10.1007/s00011-020-01341-1. Epub 2020 Apr 1.PMID: 32239248 Review.
References
REFERENCES
-
- Vučković S, Srebro D, Vujović KS, Vučetić Č, Prostran M. Cannabinoids and pain: new insights from old molecules. Front Pharmacol. 2018;9:1259. doi:10.3389/fphar.2018.01259
-
- Zou S, Kumar U. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci. 2018;19(3):833. doi:10.3390/ijms19030833
-
- Schafroth MA, Mazzoccanti G, Reynoso-Moreno I, et al. Δ9-cis-Tetrahydrocannabinol: natural occurrence, chirality, and pharmacology. J Nat Prod. 2021;84:2502-2510. doi:10.1021/acs.jnatprod.1c00513
-
- Morales P, Reggio PH, Jagerovic N. An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol. Front Pharmacol. 2017;8:422. doi:10.3389/fphar.2017.00422
-
- Bisogno T, Hanuš L, Petrocellis LD, et al. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol. 2009;134(4):845-852. doi:10.1038/sj.bjp.0704327

